Table 2.
Univariate model | Multivariable model | ||||
---|---|---|---|---|---|
|
|||||
Factor | Level | OR (95% CI) | Pa | aOR (95% CI) | Pa |
Sex | Female | 0.841 (0.46, 1.45) | 0.48 | 0.50 (0.26, 0.98) | 0.04 |
Male | 1.00 (ref) | 1.00 (ref) | |||
Age at diagnosis (years) | <30 | 1.00 (ref) | <0.01 | 1.00 (ref) | <0.01 |
30–40 | 1.82 (1.05, 3.16) | 1.73 (0.98, 3.05) | |||
40–50 | 2.21 (1.27, 3.83) | 2.07 (1.16, 3.68) | |||
>50 | 5.73 (3.30, 9.94) | 4.91 (2.74, 8.76) | |||
Mode of probable HIV exposure | MSM | 1.00 (ref) | <0.01 | 1.00 (ref) | <0.01 |
Heterosexual | 1.79 (1.29, 2.47) | 2.04 (1.38, 3.02) | |||
IDU | 1.61 (0.82, 3.17) | 1.96 (0.92, 4.18) | |||
Other | 2.70 (1.49, 4.88) | 2.05 (1.08, 3.86) | |||
Continental region of birth | Australia | 1.00 (ref) | 0.02 | 1.00 (ref) | <0.01 |
New Zealand/Pacific Islander | 0.69 (0.25, 2.09) | 0.72 (0.22, 2.20) | |||
Africa | 2.89 (1.23, 6.81) | 3.87 (1.49, 10.08) | |||
Americas | 3.15 (1.18, 8.41) | 2.60 (0.88, 7.70) | |||
Asia | 1.88 (1.12, 3.16) | 2.57 (1.44, 4.58) | |||
Europe | 1.75 (1.02, 2.99) | 1.78 (0.98, 3.21) | |||
Not reported | 1.27 (0.88, 1.82) | 0.79 (0.53, 1.20) | |||
Hepatitis B co-infection | Positive | 1.45 (0.69, 3.08) | 0.14 | 1.41 (0.64, 3.15) | 0.67 |
Negative | 1.00 (ref) | 1.00 (ref) | |||
Not reported | 0.73 (0.49, 1.07) | 1.08 (0.64, 1.75) | |||
Hepatitis C co-infection | Positive | 1.00 (0.58, 1.71) | 0.27 | 0.99 (0.54, 1.81) | 0.41 |
Negative | 1.00 (ref) | 1.00 (ref) | |||
Not reported | 0.64 (0.37, 1.10) | 0.62 (0.31, 1.25) | |||
Australian state capital city setting | Capital city | 1.00 (ref) | 0.02 | 1.00 (ref) | <0.01 |
Non-capital city | 1.43 (1.06, 1.92) | 2.40 (1.34, 4.31) | |||
Primary care setting | General practice | 0.69 (0.50, 0.96) | <0.01 | 1.36 (0.75, 2.45) | <0.01 |
Hospital clinic | 1.43 (1.00, 2.02) | 2.88 (1.57, 5.30) | |||
Sexual health clinic | 1.00 (ref) | 1.00 (ref) | |||
Year of HIV diagnosis | 1996–2000 | 1.00 (ref) | <0.01 | 1.00 (ref) | <0.01 |
2001–2006 | 0.46 (0.32, 0.65) | 0.44 (0.31, 0.67) | |||
2007–2012 | 0.72 (0.51, 1.02) | 0.70 (0.48, 1.02) |
Wald test for categorical level heterogeneity. MSM=men who have sex with men; IDU=injecting drug use.